GROOVE BOTANICALS INC. (GRVE): auditor change — Groove Botanicals replaces auditor; prior reports noted going concern doubts

GROOVE BOTANICALS INC.

Former auditor M. S. Madhava Rao resigned May 13, 2026; no reason given; effective immediately.
Board engaged GSKCA & Associates as new independent registered public accounting firm on same date.
Madhava Rao's reports for FY2025 and FY2024 included explanatory paragraph about substantial doubt on going concern.
No disagreements or reportable events between company and former auditor during covered periods.
Company authorized former auditor to respond fully to successor's inquiries.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.95

M. S. Madhava Rao resigned as auditor of GROOVE BOTANICALS INC..

Action: resignation
Auditor: M. S. Madhava Rao

Exact text from the filing

On May 13, 2026, M. S. Madhava Rao, Chartered Accountant (PCAOB ID 06662) (“Madhava Rao”) resigned as the independent registered public accounting firm of GROOVE BOTANICALS, INC., a Nevada corporation (the “Company”), effective immediately.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.95

GROOVE BOTANICALS INC. engaged GSKCA & Associates as its auditor.

Action: engagement
Auditor: GSKCA & Associates

Exact text from the filing

On May 13, 2026, concurrently with its acceptance of Madhava Rao’s resignation, the Board of Directors of the Company (acting in its capacity as the Company’s audit committee) approved the engagement of GSKCA & Associates (“GSKCA”) as the Company’s new independent registered public accounting firm, effective immediately.

View on SEC.gov

Browse all auditor changes →

GROOVE BOTANICALS INC. filing history →

Source: SEC EDGAR

accession 0001477932-26-003407

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.